Lv42
422 积分 2026-08-11 加入
Epigenetic nanoagonist in PD-L1-resistant tumors
2小时前
已关闭
LIGHT costimulation with PD-1/PD-L1 and TIGIT blockade
2小时前
已完结
Immune escape behind anti-PD-1 resistance in melanoma metastasis
3小时前
已完结
Hemin blocks TIGIT/PVR and induces ferroptosis
3小时前
已完结
PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy
3小时前
已完结
CD155 as an emerging target in tumor immunotherapy
4小时前
已完结
Anti-TIGIT therapies in digestive cancers: from immune evasion to precision immunotherapy
14小时前
已完结
A phase 1a/b open-label, dose-escalation study of etigilimab alone or in combination with nivolumab
14小时前
已完结
皖公网安备34019202002308
